Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

669 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus nab-Paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin) in Patients with Metastatic Pancreatic Cancer.
Sahai V, Saif MW, Kalyan A, Philip PA, Rocha-Lima CM, Ocean A, Ondovik MS, Simeone DM, Banerjee S, Bhore R, Louis CU, Picozzi V. Sahai V, et al. Among authors: saif mw. J Pancreat Cancer. 2019 Sep 25;5(1):35-42. doi: 10.1089/pancan.2019.0012. eCollection 2019. J Pancreat Cancer. 2019. PMID: 31559379 Free PMC article.
The Role of Olaparib in Metastatic Pancreatic Cancer.
Chi J, Chung SY, Prasad S, Saif MW. Chi J, et al. Among authors: saif mw. Cancer Med J. 2021 Dec;4(3):89-91. Epub 2021 May 11. Cancer Med J. 2021. PMID: 34151318 Free PMC article. No abstract available.
New Potential Options for SBRT in Pancreatic Cancer.
Ghaly M, Gogineni E, Herman J, Saif MW. Ghaly M, et al. Among authors: saif mw. Cancer Med J. 2021 Mar;4(Suppl 3):41-50. Epub 2021 Feb 18. Cancer Med J. 2021. PMID: 34355218 Free PMC article.
A phase I pharmacologic and pharmacogenetic trial of sequential 24-hour infusion of irinotecan followed by leucovorin and a 48-hour infusion of fluorouracil in adult patients with solid tumors.
Wright MA, Morrison G, Lin P, Leonard GD, Nguyen D, Guo X, Szabo E, Hopkins JL, Leguizamo JP, Harold N, Fioravanti S, Schuler B, Monahan BP, Saif MW, Quinn MG, Pang J, Grem JL. Wright MA, et al. Among authors: saif mw. Clin Cancer Res. 2005 Jun 1;11(11):4144-50. doi: 10.1158/1078-0432.CCR-04-2439. Clin Cancer Res. 2005. PMID: 15930350 Clinical Trial.
669 results